Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
The scope of the problem: Past and Future
Scientific background, Practical aspects: coronary artery disease, Heart failure, Aortic aneurysm and dissection, Peripheral arterial disease, Stroke, Practical aspects: prevention and management of stroke |
Prevention strategies and policy issues
Scientific background, Practical aspects: policy issues, Prevention in clinical practice
|
How to evaluate scientific evidence
Scientific background, What is "evidence"?, Grading of evidence, The problems of evidence and guidance, Practical aspects |
Priorities, total risk estimation, and objectives
Introduction, Priorities, Total risk estimation, How do I assess risk ? |
Principles of behaviour change and management of behavioural risk factors
Scientific background, The physicians/caregiver-patient interaction as a means towards behavioural change, Specialized and multimodal interventions, Practical aspects: management of behavioural risk factors
|
Smoking
Scientific background, Practical aspect: prevention and management of smoking
|
Nutrition
Scientific background, Practical aspects: management
|
Overweight and obesity
Scientific background, Body weight and risk, Which index of obesity is the best predictor of cardiovascular risk and cardiovascular risk factors-body mass index (BMI), waist circumference (WC), or waist-hip circumference ratio (WHR)?, Imaging and fat distribution, Practical aspects: managements of obesity and overweight, Physical activity and body weight, Diet and behavioural interventions, Drug treatment of overweight
|
Physical activity
Scientific background, Estimating physical activity, Practical aspects: management
|
Heart rate
Scientific background, Practical aspects: management
|
Blood pressure
Scientific background, Risk stratification and target organ damage, Practical aspects: management of hypertension, Who to treat, How to treat, Antihypertensive drugs, Desirable blood pressure, Duration of treatment
|
Plasma lipids
Scientific background, Practical aspects: management, Should statins be given to all persons with cardiovascular disease?
|
Diabetes
Scientific background, Practical aspects: management
|
The metabolic syndrome
Scientific background, Practical aspects: management |
Psychosocial factors
Scientific background, Practical aspects: management of psychosocial risk factors in clinical practice |
Imflammation markers and haemostatic factors
Scientific background |
Genetic factors
Family history: scientific background, Family history: practical aspects, Phenotypes: scientific background, Genotypes: scientific background, DNA-based tests for risk prediction, Practical aspects, DNA-based tests for risk prediction, Pharmacogenetics, Severe familial dyslipidaemias and coronary heart disease, Familial hypercholesterolaemia (FH), Familial combined hyperlipidaemia (FCH) , Familial high-density lipoprotein deficiency syndromes |
New imaging methods to detect asymptomatic individuals at high risk for cardiovascular events
|
Gender issues: cardiovascular disease prevention in women
Scientific background, Practical aspects |
Renal impairment as a risk factor in cardiovascular disease prevention
Scientific background, Practical aspect: management |
Cardioprotective drug therapy
Scientific background, Antiplatelet therapies, B-Blockers, ACE inibitors, Anticoagulation, Practical aspects: management, Antiplatelet therapy: aspirin, Antiplatelet therapy: clopidogrel, B-Blockers, ACE inhibitors, Calcium channel blockers, Diuretics, Anticoagulation |
Implementation strategies
Scientific background, Barriers to the implementation of guidelines, Doctor-patient relationship, Practical aspects, Important arenas for training, Implementation strategies |